RhumbLine Advisers’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-279,220
Closed -$1.06M 3171
2020
Q1
$1.06M Sell
279,220
-83
-0% -$315 ﹤0.01% 1856
2019
Q4
$1.42M Buy
279,303
+18,508
+7% +$94.2K ﹤0.01% 1934
2019
Q3
$1.32M Buy
260,795
+3,467
+1% +$17.5K ﹤0.01% 1917
2019
Q2
$1.59M Buy
257,328
+16,567
+7% +$102K ﹤0.01% 1862
2019
Q1
$1.12M Sell
240,761
-1,973
-0.8% -$9.15K ﹤0.01% 1985
2018
Q4
$1.02M Buy
242,734
+45,483
+23% +$191K ﹤0.01% 2000
2018
Q3
$1.24M Buy
197,251
+17,537
+10% +$110K ﹤0.01% 1905
2018
Q2
$1.45M Buy
179,714
+15,080
+9% +$121K ﹤0.01% 1847
2018
Q1
$1.23M Buy
164,634
+5,074
+3% +$37.8K ﹤0.01% 1844
2017
Q4
$949K Buy
159,560
+20,853
+15% +$124K ﹤0.01% 1972
2017
Q3
$1.02M Buy
138,707
+2,970
+2% +$21.9K ﹤0.01% 1963
2017
Q2
$922K Sell
135,737
-32
-0% -$217 ﹤0.01% 1986
2017
Q1
$1.28M Buy
135,769
+58,042
+75% +$548K ﹤0.01% 1804
2016
Q4
$672K Buy
77,727
+4,204
+6% +$36.3K ﹤0.01% 2069
2016
Q3
$465K Sell
73,523
-7,465
-9% -$47.2K ﹤0.01% 2248
2016
Q2
$342K Buy
80,988
+11,223
+16% +$47.4K ﹤0.01% 2451
2016
Q1
$304K Buy
69,765
+635
+0.9% +$2.77K ﹤0.01% 2523
2015
Q4
$424K Buy
69,130
+4,405
+7% +$27K ﹤0.01% 2350
2015
Q3
$370K Buy
64,725
+2,322
+4% +$13.3K ﹤0.01% 2424
2015
Q2
$466K Sell
62,403
-26,890
-30% -$201K ﹤0.01% 2382
2015
Q1
$534K Buy
89,293
+2,800
+3% +$16.7K ﹤0.01% 2268
2014
Q4
$654K Buy
86,493
+6,700
+8% +$50.7K ﹤0.01% 2093
2014
Q3
$414K Hold
79,793
﹤0.01% 2331
2014
Q2
$344K Buy
79,793
+27,914
+54% +$120K ﹤0.01% 2507
2014
Q1
$212K Sell
51,879
-1,910
-4% -$7.81K ﹤0.01% 2739
2013
Q4
$287K Hold
53,789
﹤0.01% 2609
2013
Q3
$271K Buy
53,789
+72
+0.1% +$363 ﹤0.01% 2602
2013
Q2
$240K Buy
+53,717
New +$240K ﹤0.01% 2843